Bookmark

Add to MyYahoo RSS

Bristol-Myers Squibb News

News on Bristol-Myers Squibb continually updated from thousands of sources around the net.

Monday | Business Journal

Bristol-Myers Squibb targets major block of space in East Cambridge

Bristol-Myers Squibb is vetting several property options in East Cambridge, increasingly the office and lab market of choice for many of the largest life sciences companies in the world.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals, Waltham, MA

INCROYABLE - Relais France 4x400m Femme - Championnats d'Europe 2014 - INCREDIBLE F...

Watch A Tortoise Chase Down A Remote-Controlled Truck With ALL ITS MIGHT

Police Fatally Shoot Another Black Male Near Ferguson

Critics Slam 'Ice Bucket Challenge' as 'Slacktivism' and 'Stunt Philanthropy'

Thu Aug 07, 2014

JD Supra

Court Report -- Part II: August 2014

Medicines Company v. Accord Healthcare, Inc. et al. 1:14-cv-00626; filed July 24, 2014 in the Middle District of North Carolina Infringement of U.S. Patent Nos.

Comment?

Related Topix: 9, Biotech, Medicines Company The, Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Pharmaceuticals

Sys-Con Media

Leica Biosystems and Bristol-Myers Squibb Enter Into a Development...

Leica Biosystems will develop fully automated tissue-based companion diagnostic tests to run on the BONDa automated advanced staining systems Leica Biosystems, today announced an agreement with Bristol-Myers Squibb Company to collaborate on developing companion diagnostics on the Leica BOND system for use as an aid in selecting patients for ... (more)

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Tue Aug 05, 2014

BioSpace

Alder Biopharmaceuticals Inc. Reports Second Quarter 2014 Financial And Operating Results

Alder BioPharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, autoimmune and inflammatory diseases, today provided recent corporate highlights and reported its financial results for the second quarter ended June 30, 2014.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Psoriatic Arthritis, Health

Business Journal

Allied Minds and Bristol Myers to start 10 new biotechs in next five years

A new partnership being touted by Boston-based Allied Minds will create about 10 biotechs over the next five years - including several in the Bay State - that could then be acquired by New York drug giant Bristol-Myers Squibb .

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Mon Aug 04, 2014

Customer Interaction Solutions

Allied Minds and Bristol-Myers Squibb Form New Enterprise to Advance...

Allied Minds and Bristol-Myers Squibb Company today announced the formation of Allied-Bristol Life Sciences LLC, a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university research institutions across the U.S. Allied-Bristol Life Sciences LLC will ... (more)

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex

Fri Aug 01, 2014

Bjp.rcpsych.org

Aripiprazole once-monthly for treatment of schizophrenia:...

W. Wolfgang Fleischhacker , MD, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria; Raymond Sanchez , MD, Pamela P. Perry, MS, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey, USA; Na Jin , MS, Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, ... (more)

Comment?

Related Topix: World News, Austria, Deerfield, IL, Medicine, Pharmacology, Pfizer, Medarex

Thu Jul 31, 2014

West Australian

AstraZeneca raises earnings outlook as sales climb

British-Swedish drugmaker AstraZeneca, which fought off a takeover from Pfizer earlier this year, raised its 2014 earnings outlook on Thursday and posted rising second-quarter sales.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Wed Jul 30, 2014

GuruFocus.com

Vanguard Health Care Fund's Top Second Quarter Stocks

Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.

Comment?

Related Topix: Financial Markets, Biotech, Merck , Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Pharmaceuticals

The Daily Caller

Selena Gomez Shows Off Skin In Snakeskin Halter Top

The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .

Comment?

Related Topix: Charitable Organizations, American Cancer Society, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry

Tue Jul 29, 2014

Pharmaceutical Processing

European Commission Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Bristol-Myers Squibb and Pfizer announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Pfizer

Mon Jul 28, 2014

Pharmaceutical Technology

Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies

Bristol-Myers Squibb and Ono Pharmaceutical signed a collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea, and Taiwan.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Health, Lung Cancer

Fri Jul 25, 2014

BioSpace

Bristol-Myers Squibb Company Taps Bay Area's Redwood City For...

Bristol-Myers Squibb Company Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce July 25, 2014 By Renee Morad , BioSpace.com Breaking News Staff Bristol-Myers Squibb Co.

Comment?

Related Topix: Bristol Myers Squibb, Biotech, Medicine, Healthcare Industry, San Mateo County, CA, Redwood City, CA, Startups, BioSpace.com, Bloomsbury Publishing, Publishing, Media, Pharmaceuticals

Thu Jul 24, 2014

BioSpace

Bristol-Myers Squibb Company Appoints As India Country Head

Bristol-Myers Squibb India appointed Jitendra Tyagi as the BMS India country head.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Bloomsbury Publishing, Publishing, Media, Medarex, Pharmaceuticals

Wed Jul 23, 2014

Customer Interaction Solutions

Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce...

Ono Pharmaceutical Co., Ltd. have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Health, Lung Cancer

The Motley Fool

Earnings Preview: Bristol-Myers Squibb and Celgene Corporation

Most health care stocks have been experiencing a roller coaster ride so far this year.

Comment?

Related Topix: Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Medarex, Pharmaceuticals, Biotech, Celgene, Medicine, Healthcare Industry

Forbes.com

Forbes Earnings Preview: Bristol Myers Squibb

Bristol Myers Squibb reports its second-quarter earnings on Thursday, July 24, 2014, and the consensus earnings per share estimate is 45 cents per share.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Pharmaceuticals, Healthcare Industry, Financial Markets

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••